News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,963 Results
Type
Article (39403)
Company Profile (304)
Press Release (647256)
Section
Business (204759)
Career Advice (2000)
Deals (35473)
Drug Delivery (86)
Drug Development (80990)
Employer Resources (168)
FDA (16134)
Job Trends (14856)
News (345790)
Policy (32559)
Tag
Academia (2548)
Alliances (49384)
Alzheimer's disease (1225)
Approvals (16053)
Artificial intelligence (122)
Bankruptcy (354)
Best Places to Work (11512)
Biotechnology (213)
Breast cancer (112)
Cancer (971)
Cardiovascular disease (82)
Career advice (1669)
Cell therapy (212)
Clinical research (64133)
Collaboration (341)
Compensation (173)
COVID-19 (2541)
C-suite (85)
Data (941)
Diabetes (141)
Diagnostics (6134)
Earnings (84617)
Employer resources (146)
Events (109617)
Executive appointments (256)
FDA (16600)
Funding (304)
Gene therapy (155)
GLP-1 (571)
Government (4342)
Healthcare (18681)
Infectious disease (2620)
Inflammatory bowel disease (105)
Interviews (308)
IPO (16308)
Job creations (3658)
Job search strategy (1427)
Layoffs (414)
Legal (7884)
Lung cancer (158)
Manufacturing (159)
Medical device (13164)
Medtech (13169)
Mergers & acquisitions (19200)
Metabolic disorders (377)
Neuroscience (1471)
NextGen Class of 2024 (6532)
Non-profit (4475)
Northern California (1307)
Obesity (223)
Opinion (181)
Patents (96)
People (56480)
Phase I (19928)
Phase II (28245)
Phase III (21070)
Pipeline (320)
Postmarket research (2554)
Preclinical (8484)
Radiopharmaceuticals (234)
Rare diseases (190)
Real estate (5934)
Regulatory (21541)
Research institute (2314)
Resumes & cover letters (350)
Southern California (1168)
Startups (3613)
United States (12332)
Vaccines (544)
Weight loss (164)
Date
Today (232)
Last 7 days (1068)
Last 30 days (3285)
Last 365 days (35581)
2024 (31279)
2023 (40184)
2022 (51293)
2021 (55843)
2020 (54163)
2019 (46648)
2018 (35125)
2017 (32224)
2016 (31631)
2015 (37709)
2014 (31455)
2013 (26501)
2012 (28770)
2011 (29427)
2010 (27525)
Location
Africa (716)
Arizona (188)
Asia (37257)
Australia (6090)
California (2954)
Canada (1208)
China (225)
Colorado (128)
Connecticut (131)
Europe (79814)
Florida (415)
Georgia (104)
Illinois (323)
Indiana (188)
Kansas (97)
Maryland (543)
Massachusetts (2383)
Michigan (146)
Minnesota (257)
New Jersey (868)
New York (877)
North Carolina (675)
Northern California (1307)
Ohio (131)
Pennsylvania (782)
South America (1094)
Southern California (1168)
Texas (407)
Utah (84)
Washington State (336)
686,963 Results for "greenlight biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
GreenLight Biosciences Secures EPA Registration for New Bioinsecticide, Calantha, Historic Step Towards A Safer and More Sustainable Food System
GreenLight Biosciences (GreenLight Bio) has been granted registration by the U.S. Environmental Protection Agency (EPA) and several states for its groundbreaking Calantha™ product, designed to target and control the highly destructive Colorado potato beetle.
January 4, 2024
·
5 min read
Deals
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that it is initiating the final steps in closing its previously announced merger with SW MergerCo, Inc. (“Merger Sub”) and SW ParentCo, Inc (“Parent”).
July 20, 2023
·
6 min read
Deals
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
GreenLight Biosciences Holdings, PBC announced the closing of its previously announced merger with SW MergerCo, Inc. and SW ParentCo, Inc., pursuant to which Merger Sub merged with and into GreenLight with GreenLight surviving as a wholly-owned subsidiary of Parent.
July 24, 2023
·
5 min read
COVID-19
FDA Greenlights Updated COVID-19 Shots from Pfizer, Moderna for Fall Season
The regulator on Thursday said the mRNA vaccines, Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax, will better protect against currently circulating variants as COVID continues to surge in many parts of the U.S.
August 23, 2024
·
2 min read
·
Tristan Manalac
Genetown
GreenLight Biosciences Releases Inaugural Sustainability Report
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today released its inaugural Sustainability Report.
April 12, 2023
·
6 min read
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Business
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
GreenLight Biosciences, PBC, a biotechnology company dedicated to making RNA products affordable and accessible for human health and agriculture, reported operational highlights and financial results for the first quarter ended March 31, 2023.
May 11, 2023
·
10 min read
Business
Xenetic Biosciences, Inc. Announces Executive Leadership Transition
Xenetic Biosciences, Inc. today announced the appointment of James Parslow, the Company’s Chief Financial Officer, as interim Chief Executive Officer, effective May 16, 2024.
May 22, 2024
·
5 min read
FDA
FDA Greenlights Two Interchangeable Biosimilars to Regeneron’s Eylea
The regulator on Monday approved two interchangeable biosimilars to Regeneron’s Eylea, providing additional competition for the pharma’s blockbuster as key patent protections are set to expire.
May 21, 2024
·
2 min read
·
Tristan Manalac
Genetown
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
GreenLight Biosciences confirmed that it has received a non-binding indication of interest from Fall Line Endurance Fund, L.P. to acquire all of the outstanding capital stock of the Company for $0.60 per share in cash.
March 30, 2023
·
6 min read
1 of 68,697
Next
